• Contact us
  • Advertising Policy
  • Cookie Policy
  • Disclaimer
  • Privacy Policy
  • Terms of Use
Friday, July 11, 2025
32 °c
Agartala
enewstime
  • Home
  • News
    • Northeast
    • National
    • International
    • Tripura News
  • Sports
    3rd Test: Pope has his 'fingers crossed' as Stokes battles injury at Lord’s

    3rd Test: Pope has his 'fingers crossed' as Stokes battles injury at Lord’s

    'I have asked him for some tips..': Reddy credits Cummins’ advice for bowling success at Lord’s

    'I have asked him for some tips..': Reddy credits Cummins’ advice for bowling success at Lord’s

    3rd Test: Rotation of bowlers will be a critical thing, says Mel Jones

    3rd Test: Rotation of bowlers will be a critical thing, says Mel Jones

    Hockey India names 33-man core group for senior men's national camp

    Hockey India names 33-man core group for senior men's national camp

    Bengaluru to host Indian Open Para Athletics Championship on July 11–12

    Bengaluru to host Indian Open Para Athletics Championship on July 11–12

    Club WC: Enrique motivates PSG to 'make history' after routing Real Madrid

    Club WC: Enrique motivates PSG to 'make history' after routing Real Madrid

    Red Bull sack F1 team principal Christian Horner

    Red Bull sack F1 team principal Christian Horner

    Stuart Broad labels Australia’s current top three 'the most muddled'

    Stuart Broad labels Australia’s current top three 'the most muddled'

    NZ opener Allen ruled out of Zimbabwe tri-series with foot injury

    NZ opener Allen ruled out of Zimbabwe tri-series with foot injury

  • Business
  • Entertainment
  • Health
  • Features
  • TendersNew
No Result
View All Result
  • Home
  • News
    • Northeast
    • National
    • International
    • Tripura News
  • Sports
    3rd Test: Pope has his 'fingers crossed' as Stokes battles injury at Lord’s

    3rd Test: Pope has his 'fingers crossed' as Stokes battles injury at Lord’s

    'I have asked him for some tips..': Reddy credits Cummins’ advice for bowling success at Lord’s

    'I have asked him for some tips..': Reddy credits Cummins’ advice for bowling success at Lord’s

    3rd Test: Rotation of bowlers will be a critical thing, says Mel Jones

    3rd Test: Rotation of bowlers will be a critical thing, says Mel Jones

    Hockey India names 33-man core group for senior men's national camp

    Hockey India names 33-man core group for senior men's national camp

    Bengaluru to host Indian Open Para Athletics Championship on July 11–12

    Bengaluru to host Indian Open Para Athletics Championship on July 11–12

    Club WC: Enrique motivates PSG to 'make history' after routing Real Madrid

    Club WC: Enrique motivates PSG to 'make history' after routing Real Madrid

    Red Bull sack F1 team principal Christian Horner

    Red Bull sack F1 team principal Christian Horner

    Stuart Broad labels Australia’s current top three 'the most muddled'

    Stuart Broad labels Australia’s current top three 'the most muddled'

    NZ opener Allen ruled out of Zimbabwe tri-series with foot injury

    NZ opener Allen ruled out of Zimbabwe tri-series with foot injury

  • Business
  • Entertainment
  • Health
  • Features
  • TendersNew
No Result
View All Result
enewstime
  • Home
  • News
  • Sports
  • Business
  • Entertainment
  • Health
  • Features
  • Tenders
Home Health

DRDO’s anti-Covid drug 2-DG launched

ENEWSTIME Desk by ENEWSTIME Desk
May 17, 2021
in Health
30
VIEWS
Share on FacebookShare on Twitter

The first batch of DRDO-developed anti-Covid drug 2-DG (2-deoxy-D-glucose) was launched on Monday to treat patients suffering from the deadly disease. The medicine comes in powder form and can be taken with water.

Defence Minister Rajnath Singh and Health Minister Harsh Vardhan released the first batch of the 2-DG, an anti-Covid-19 therapeutic application of the drug developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development Organisation (DRDO) in collaboration with Dr Reddy’s Laboratories (DRL).

Rajnath Singh handed over the anti-Covid drug to his cabinet colleague Harsh Vardhan who handed over it to Delhi All India Institute of Medical Sciences (AIIMS) director Randeep Guleria at an event here.

The Defence Minister would be later distributing around 10,000 doses of the drug to a few hospitals in the national capital.

The Drugs Controller General of India (DCGI) granted emergency use nod for the drug last week. The drug could be a game-changer in the battle against pandemic as it helps in faster recovery of hospitalised patients and reduces oxygen dependence.

Clinical trial results have shown that the drug helps in faster recovery of hospitalised patients and reduces supplemental oxygen dependence. Higher proportion of patients treated with 2-DG showed RT-PCR negative conversion in Covid patients.

The medicine was found to be safe for Covid-19 patients in phase 2 trials, conducted between May and October last year. It was found to be effective in cutting short the hospital stays of Covid patients and reducing their supplemental oxygen dependence.

During the first wave of the pandemic in April last year, INMAS-DRDO scientists conducted laboratory experiments with the help of Centre for Cellular and Molecular Biology (CCMB), Hyderabad, and found that this molecule works effectively against SARS-CoV-2 virus and inhibits the viral growth.

Based on these results, the Drugs Controller General of India (DCGI) Central Drugs Standard Control Organisation (CDSCO) permitted Phase-II clinical trial of 2- DG in Covid-19 patients in May 2020. The DRDO, along with its industry partner DRL, Hyderabad, started the clinical trials to test the safety and efficacy of the drug in Covid-19 patients.

In Phase-II trials (including dose ranging) conducted during May-October 2020, the drug was found to be safe in Covid-19 patients and showed significant improvement in their recovery. Phase-II was conducted in six hospitals and Phase IIb (dose ranging) clinical trial was conducted at 11 hospitals all over the country. Phase-II trial was conducted on 110 patients

Related Posts

World Population Day: Planned parenthood key for better maternal, child health, says Nadda
Health

World Population Day: Planned parenthood key for better maternal, child health, says Nadda

July 11, 2025
Microsoft’s new AI system to help decode protein motion, advance drug discovery: Satya Nadella
Health

Microsoft’s new AI system to help decode protein motion, advance drug discovery: Satya Nadella

July 11, 2025
From farms to factories: How Tamil Nadu’s incubation hubs are boosting rural livelihoods
Health

From farms to factories: How Tamil Nadu’s incubation hubs are boosting rural livelihoods

July 11, 2025
Disability services must include health screening, stress management for caregivers: Study
Health

Disability services must include health screening, stress management for caregivers: Study

July 10, 2025
Former Telangana CM KCR again admitted to hospital
Health

Former Telangana CM KCR again admitted to hospital

July 10, 2025
Diabetes may raise infection, blood clot risk post knee replacement surgery: Study
Health

Diabetes may raise infection, blood clot risk post knee replacement surgery: Study

July 10, 2025
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
D-2050 D-2050 D-2050
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT

About us

Enewstime.in is run by an individual – a Journalist by profession of Tripura with the active help of several journos including senior journalists of the State. On top of that, Enewstime.in being a subscriber of IANS news agency, we have plenty of multi-choice topics to offer to our esteemed readers. Enewstime.in is a venture reach global audience from a tiny State Tripura.

Latest News

Awami League Slams ICT Alleging Coercion of Ex-IGP to Testify Against Hasina

Bloodshed in West Bengal’s Bhangar returns

World Population Day: Planned parenthood key for better maternal, child health, says Nadda

Anupam Kher on President watching ‘Tanvi The Great’: She’s the epitome of different but no less

Income Tax Dept releases excel utilities for ITR-2 and ITR-3 forms

3rd Test: Pope has his 'fingers crossed' as Stokes battles injury at Lord’s

Contact us

19, Old Thana Road. Banamalipur. PO. Agartala. Pin code 799001. Tripura (West), India.

Email: enewstime2017@gmail.com

Wa: 8794548041

  • Contact us
  • Advertising Policy
  • Cookie Policy
  • Disclaimer
  • Privacy Policy
  • Terms of Use

© 2025 Designed & Developed with ❤️ by Provibe Media LLP

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • News
    • Northeast
    • National
    • International
    • Tripura News
  • Sports
  • Business
  • Entertainment
  • Health
  • Features
  • Tenders

© 2025 Designed & Developed with ❤️ by Provibe Media LLP